Financial disclosures of AIDS researchers - 7/14/04 JAMA

While these financial disclosures include many of the doctors who were involved in AIDS treatment from the very beginning, it includes nearly all of those who dictate the AIDS standard of treatment today.

As our esteemed tenured professor of medicine at NYU might say "Plus Ca Change, Plus C'est la Meme Chose" (The More Things Change, the

More They Stay the Same).

Is this the stuff of good science or has this been an orgy of greed from the very beginning?

As we look at those who control the world of AIDS treatments on planet Earth, why don't you be the judge

:

JAMA, July 14, 2004 Vol 292, No. 2 251-265

Treatment for Adult 2004 Recommendations International AIDS Society - USA Panel

Patrick G. Yeni, MD

Scott M. Hammer, MD

Martin S. Hirsch, MD

Michael S. Saag, MD

Mauro Schechter, MD, PhD

Charles C. J. Carpenter, MD

Margaret A. Fischl, MD

Jose M. Gatell, MD, PhD

Brian G. Gazzard, MA, MD

Donna M. Jacobsen, BS

David A. Katzenstein, MD

Julio S. G. Montaner, MD

Douglas D. Richman, MD

Robert T. Schooley, MD

Melanie A. Thompson, MD

Stefano Vella, MD

Paul A. Volberding, MD

Patrick G. Yeni, MD

Dr Yeni has received research grants for site investigator

from GlaxoSmithKline, Bristol- Myers Squibb, Boehringer

Ingelheim, Roche, Tibotec/Virco, and Gilead.

Dr Yeni has received honoraria for advisory positions and lecture

sponsorships from Abbott Laboratories, Bristol-Myers Squibb,

Boehringer Ingelheim, Roche, Tibotec/Virco, and Merck Sharp

and Dohme.

Scott M. Hammer, MD

Dr Hammer has received research grants for site investigator from

Roche, GlaxoSmithKline, and Merck.

Dr Hammer has been a consultant for Bristol-Myers

Squibb, GlaxoSmithKline, Merck, Shionogi, Pfizer, Boehringer

Ingelheim, Shire, Gilead, and Tibotec/ Virco.

Martin S. Hirsch, MD

Dr Hirsch has received research support from Takeda.

Dr Hirsch has been a consultant for Schering Plough, GlaxoSmithKline,

and Bristol-Myers Squibb.

Michael S. Saag, MD

Dr Saag has received research support from Abbott Laboratories,

Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Ortho

Biotech/Johnson&Johnson, Pfizer/Agouron, and Hoffmann- LaRoche.

Dr Saag has been a consultant for Abbott Laboratories, Boeringer

Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline,

OrthoBiotech/Johnson & Johnson, Pfizer/Agouron, Roche,

Schering-Plough, Shire Pharmaceutical, TherapyEdge, Tibotec/ Virco,

Trimeria, Vertex, and ViroLogic.

Dr Saag has received honoraria for positions on the speakers

bureau for Abbott Laboratories, Boeringer Ingelheim, Bristol-Myers

Squibb, Gilead Sciences, GlaxoSmithKline, OrthoBiotech,

Johnson & Johnson, Pfizer, Agouron, Roche, Schering-Plough,

Shire Pharmaceutical, TherapyEdge, Tibotec/Virco, Trimeria,

Vertex, and ViroLogic.

Margaret A. Fischl, MD

Dr Fischl has received research grants from Abbott Laboratories,

Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, and

Ortho Biotech.

Dr Fischl has received honoraria for continuing medical education

programs from GlaxoSmithKline.

Dr Fischl has served as an advisor for Agouron Pharmaceuticals and

GlaxoSmithKline.

Brian G. Gazzard, MA, MD

Dr Gazzard has received research grants from Abbott Laboratories,

Boehringer Ingelheim, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb,

and Johnson &Johnson.

Julio S. G. Montaner, MD

Dr Montaner has received grants from Abbott Laboratories,

Agouron Pharmaceuticals, Shire Biochemical, Boehringer

Ingelheim, Bristol-Myers Squibb, DuPont Pharma, Gilead

Sciences, GlaxoSmithKline, Roche, Kucera Pharmaceutical,

Merck Frosst Laboratories, Pharmacia & Upjohn, and Trimeris.

Dr Montaner has received honoraria for speaking from Abbott

Laboratories, Agouron Pharmaceuticals, Shire Biochemical,

Boehringer Ingelheim, Bristol-Myers Squibb, DuPont Pharma,

Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Kucera

Pharmaceutical, Merck Frosst Laboratories, Pharmacia &

Upjohn, and Trimeris Inc.

Dr Montaner holds 2 US patents, one regarding use of nevirapine

and another regarding pharmacological applications of mitochondrial

DNA assays. Dr Montaner has 2 patent applications that are

pending, one regarding pharmacological applications of

mitochondrial DNA assays and another regarding sepsis.

Robert T. Schooley, MD

Dr Schooley has received grants from GlaxoSmithKline,

Bristol-Myers Squibb, Merck, and Tibotec/Virco.

Dr Schooley has been a consultant for Abbott

Laboratories, Pfizer, Hoffmann-LaRoche, GlaxoSmithKline,

BristolMyers Squibb, Merck, Vertex, ViroLogic, and

Tibotec/Virco.

Melanie A. Thompson, MD

Dr Thompson has received grants from Abbott Laboratories, Agouron/

Pfizer Pharmaceuticals, Boeringer Ingelheim, Bristol-Myers

Squibb, Chiron Corporation, GlaxoSmithKline, Gilead

Sciences, Merck Research Laboratories, Oxo-Chemie, Roche,

Serono, Theratechnologies, Triangle Pharmaceuticals,

Trimeris, and VaxGen.

Dr Thompson has been a consultant for Abbott

Laboratories, Agouron/Pfizer Pharmaceuticals,

GlaxoSmithKline, Gilead Sciences, Serono, and Triangle

Pharmaceuticals.

Dr Thompson has received honoraria for lecture sponsorships and

continuing medical education from Abbott Laboratories,

Agouron/ Pfizer Pharmaceuticals, Boeringer Ingleheim,

Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, Roche,

Serono, Triangle Pharmaceuticals, and Trimeris.

Mauro Schechter, MD, PhD

Dr Schechter has received honoraria from Abbott Laboratories,

Bristol-Myers Squibb, GlaxoSmithKline, Merck, and Roche.

Dr Schechter has been a consultant for Abbott Laboratories,

BristolMyers Squibb, GlaxoSmithKline, Merck, and Roche.

Jose M. Gatell, MD, PhD

Dr Gatell has served in advisory positions for Roche, Bristol-Myers

Squibb, Merck Sharp and Dohme, GlaxoSmithKline, Gilead,

Boehringer Ingelheim, Abbott Laboratories, Tibotec/ Virco.

Brian G. Gazzard, MA, MD

Dr Gazzard has received lectureship fees from Abbott Laboratories,

Boehringer Ingelheim, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb,

and Johnson & Johnson.

David A. Katzenstein, MD

Dr Katzenstein has held advisory positions at Boehringer Ingelheim,

Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck,

ViroLogic, Visible Genetics, and the Doris Duke Charitable Trust.

Dr Katzenstein holds a US patent for polymerase chain reaction

assays monitoring antiviral therapy and making therapeutic

decisions in the treatment of AIDS.

Stefano Vella, MD

Dr Vella has received lecture sponsorship for

satellite symposia and continuing medical education programs

from Merck, Agouron, Gilead, Boehringer Ingelheim, and

Roche.

Paul A. Volberding, MD

Dr Volberding has received honoraria from Gilead,

Bristol-Myers Squibb, GlaxoSmithKline, and Boehringer

Ingelheim.

Dr Volberding has been a consultant for Pfizer, Bristol-Myers

Squibb, and Shire.

Douglas D. Richman, MD

Dr Richman has been a consultant for Abbott Laboratories,

Bristol-Myers Squibb, Chiron, Gilead, GlaxoSmithKline,

Merck, Novirio, Pfizer, Roche, Takeda, Triangle, and

ViroLogic.

AIDS Apologists VS AIDS Dissidents - The Truth About AIDS Denialists AIDS Apologists VS AIDS Dissidents - Truths About AIDS Denialists

AIDS Apologists VS AIDS Dissidents - The Truth About AIDS Denialists AIDS apologists are those who know HIV leads to AIDS (proven by science, so much scientific proof) and we are defending the scientifically known fact that viral pathogenesis and progression of 'HIV to AIDS' causes the eventual need for combination therapies to prolong life. Mixed "AIDS Apologist" links here or find comments here from both sides (dissidents and the scientific community), but still about AIDS Apologist activities...

AIDS dissidents (better known as AIDS Denialists who are AIDS dissidence, dissidence is anti-establishment like, against science and progression, argumentative) deny HIV causes AIDS and claim the medications kill the patients (AZT "over use" alone started this myth in the late 80s, but medicine combo/therapies are working today in the year 2000+). Basically a group of non doctors and non scientists who challenge the conventional HIV/AIDS model or hypothesis and do not accept the proven evidence. These dissident groups seem almost fanatical by them posting the same message multiple times to a targeted list of internet websites (non dissident sites of course, clogging up the normal flow of reading material with intentions of shutting the sites down) and insulting/bashing anyone who may not agree.

What are AIDS dissidents? Find out who, what, where, when and why:
http://www.hivforum.com/?dissident=dissident+site:aegis.com

What are AIDS denialists all about? See the myths exposed:
http://www.hivforum.com/?dissident=dissident+site:thebody.com

Learn about how they are murdering HIV positive people:
http://www.medchecker.com/dissident/aids-dissidents.htm

Thanks.
http://www.HIVforum.com